Because Nrg4 transgenic mice exhibited reduced fat mass and elevated energy expenditure, our findings raise the possibility that Nrg4/ErbB4 signaling may be a genetic factor for human obesity and its associated metabolic disorders. The gene discussed is ERBB4; the disease is metabolic disease.